Frontiers | QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
Seroprevalence of CMV IgG and IgM in Korean women of childbearing age - Choi - 2021 - Journal of Clinical Laboratory Analysis - Wiley Online Library
Control of human cytomegalovirus infection in patients infected with human immunodeficiency virus by high levels of specific CD8+ T-cells - Clinical Microbiology and Infection
Cytomegalovirus Meningitis in an Infant with Severe Combined Immunodeficiency - The Journal of Pediatrics
PDF) QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals | PLOS ONE
25-3-1364-Dinda A. Devona
Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation - Sood - 2015 - Liver Transplantation - Wiley Online Library
Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia - Pathology
Frontiers | QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
Analysis of the QuantiFERON-CMV assay, CMV viraemia and antiviral treatment following solid organ transplantation in Western Australia - Pathology
Nutrients | Free Full-Text | Human Cytomegalovirus Reactivation During Lactation: Impact of Antibody Kinetics and Neutralization in Blood and Breast Milk | HTML
Association of CMV-Specific T Cell-Mediated Immunity with CMV DNAemia and Development of CMV Disease in HIV-1–Infected Individuals | PLOS ONE
Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney Transplant Recipients
Immunological Prediction of Cytomegalovirus (CMV) Replication Risk in Solid Organ Transplantation Recipients: Approaches for Regulating the Targeted Anti-CMV Prevention Strategies
Comparison of the Commercial QuantiFERON-CMV and Overlapping Peptide-based ELISPOT Assays for Predicting CMV Infection in Kidney
Life | Free Full-Text | Characterization of NKG2-A/-C, Kir and CD57 on NK Cells Stimulated with pp65 and IE-1 Antigens in Patients Awaiting Lung Transplant | HTML
Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients - ScienceDirect
Citomegalovirus (CMV)- ce este, simptome, diagnostic și complicații
Targeted individual prophylaxis offers superior risk stratification for cytomegalovirus reactivation after liver transplantation - Sood - 2015 - Liver Transplantation - Wiley Online Library
Infectia cu citomegalovirus sau CVM | MedLife
